Please login to the form below

Not currently logged in
Email:
Password:

Oxford BioMedica

This page shows the latest Oxford BioMedica news and features for those working in and with pharma, biotech and healthcare.

Oxford Biomedica gets £53m cash injection from Novo venture arm

Oxford Biomedica gets £53m cash injection from Novo venture arm

Cell and gene therapy specialist Oxford Biomedica has been given a £53.5m infusion of cash from Novo Holdings in exchange for a 10% stake in the company. ... John Dawson. “We are delighted that Novo Holdings has become a shareholder in Oxford Biomedica

Latest news

More from news
Approximately 3 fully matching, plus 36 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest appointments

  • Pharma industry appointments Pharma industry appointments

    Prior to this, he was non-executive director and then chairman of Oxford BioMedica, a gene-based biopharmaceutical company.

  • Dr Simon Chandler joins Ora as a senior director Dr Simon Chandler joins Ora as a senior director

    Prior to joining Ora, Dr Chandler served as principal of Sci-pHecta Consulting from 2013 and has also held leadership roles at Bausch Lamb, Ista Pharmaceuticals, NightStaRx BioPharmaceuticals and Oxford BioMedica

  • ABPI names first project director for manufacturing ABPI names first project director for manufacturing

    James Christie joins from Oxford BioMedica. The Association of the British Pharmaceutical Industry (ABPI) has named James Christie as its first project director with responsibility for manufacturing. ... Prior to joining ABPI, Christie worked for Oxford

  • Paul Blake joins Oxford BioMedica Paul Blake joins Oxford BioMedica

    John Dawson, CEO of Oxford BioMedica, said: “His insight and guidance as a Non-Executive Board member have been invaluable and his extensive experience in the strategic clinical development of innovative ... therapies will be important to Oxford

  • BIA elects six new board members BIA elects six new board members

    The remaining new appointments are Stephen Taylor of Fujifilm Diosynth Biotechnologies; Donna Hackett, director of life sciences consultancy firm KDH BioManagement; and Tim Watts, chief financial officer of Oxford BioMedica.

More from appointments
Approximately 1 fully matching, plus 4 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Origins Insights

Origins are part of the Resonant Group. Using novel research methodologies, we dig deeper to deliver authentic audience experiences that...

Latest intelligence

Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
The Evolving Role of the Sales Rep
The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
Measure your omnichannel maturity with our new tool
Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....